WallStreetZenWallStreetZen

NYSEMKT: APUS
Apimeds Pharmaceuticals Us Inc Earnings Dates, Reports, Calls

OverviewEarnings
RevenueDividendOwnership
Apimeds Pharmaceuticals Us earnings were -$1.4M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest APUS earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$311.6k, down 6.3% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, APUS reported annual earnings of -$1.4M, with 78.7% growth.

APUS earnings history

Current Revenue
$0.0
Current Earnings
-$1.4M
Current Profit Margin
0%

APUS Return on Equity

Insufficient data to display

APUS undefined

Current Company
-638.9%
Current Industry
5.5%
APUS is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when APUS announces earnings.

APUS undefined

Current Company
125.81%
Current Industry
12%

APUS vs Pharmaceutical Stocks

TickerEBITDAEarningsY/Y EarningsEPS
AMRX$503.18M-$13.05MN/A-$0.04
ALKS$463.88M$352.71M-17.94%$2.15
APUS-$1.27M-$1.39MN/A-$0.18
AQST-$36.71M-$54.24MN/A-$0.59
AKAN-$3.59M-$4.10MN/A-$3.93
View Top Pharmaceutical Stocks

Apimeds Pharmaceuticals Us Earnings Reports & History FAQ

What were Apimeds Pharmaceuticals Us's earnings last quarter?

Apimeds Pharmaceuticals Us (NYSEMKT: APUS) reported Q4 2024 earnings per share (EPS) of -$0.05, up 57.63% year over year. Total APUS earnings for the quarter were -$311.63 thousand. In the same quarter last year, Apimeds Pharmaceuticals Us's earnings per share (EPS) was -$0.12.

If you're new to stock investing, here's how to buy Apimeds Pharmaceuticals Us stock.

Is Apimeds Pharmaceuticals Us profitable or losing money?

As of the last Apimeds Pharmaceuticals Us earnings report, Apimeds Pharmaceuticals Us is currently losing money. Apimeds Pharmaceuticals Us's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$1.39 million, a 78.73% increase year over year.

What was APUS's earnings growth in the past year?

As of Apimeds Pharmaceuticals Us's earnings date in Q2 2025, Apimeds Pharmaceuticals Us's earnings has grown year over year. APUS earnings in the past year totalled -$1.39 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.